Latest Morning Briefing Stories

A New RSV Shot Could Help Protect Babies This Winter — If They Can Get It in Time

KFF Health News Original

Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.

Ohio votó a favor del aborto. Podrían seguir otros 11 estados el próximo año

KFF Health News Original

El impulso para llevar el polémico tema a los votantes llega después de la serie de victorias en las votaciones del año pasado a favor del derecho al aborto en seis estados: California, Kansas, Kentucky, Michigan, Montana y Vermont.

US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus

KFF Health News Original

The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.

Epidemic: The Scars of Smallpox

Podcast

The series finale of “Epidemic: Eradicating Smallpox” is a visit to the home of Rahima Banu, the last person with a documented case of naturally occurring variola major smallpox. When the virus was declared eradicated, she became a symbol of one of the greatest victories in global public health. What happened to Rahima Banu afterward?

States Reconsider Religious Exemptions for Vaccinations in Child Care

KFF Health News Original

Providers and health care advocates warn a proposed rule change in Montana would jeopardize immunity levels in child care centers and communities. Efforts to change vaccination exemption rules are underway in other states, too.

An Arm and a Leg: John Green vs. Johnson & Johnson (Part 2)

Podcast

The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.

Epidemic: What Good Is a Vaccine When There Is No Rice?

Podcast

What good is a vaccine when there is no rice? Episode 7 of “Eradicating Smallpox” explores the barriers public health workers face in communities where people’s basic needs aren’t being met.

Using Opioid Settlement Cash for Police Gear Like Squad Cars and Scanners Sparks Debate

KFF Health News Original

State and local governments will receive a windfall of more than $50 billion over 18 years from settlements with companies that made, sold, or distributed opioid painkillers. Using the funds for law enforcement has triggered important questions about what the money was meant for.

¿Por qué sigue siendo tan difícil encontrar vacunas contra covid para niños pequeños?

KFF Health News Original

Por primera vez desde el inicio de la pandemia, el gobierno federal no paga directamente a los fabricantes por las dosis de covid, un proceso que permitió a médicos y farmacéuticos recibir envíos de forma gratuita.

Why Is Finding Covid Shots for Young Children Still So Hard?

KFF Health News Original

In Los Angeles and elsewhere, some parents are having trouble finding the new pediatric covid shot, especially for young children. Not all pediatricians or pharmacies have it and can administer it, even if vaccines.gov says they can.

A Third of Schools Don’t Have a Nurse. Here’s Why That’s a Problem.

KFF Health News Original

School nurses treat children daily for a wide range of illnesses and injuries, and sometimes serve as a young patient’s only health provider. They also function as a point person for critical public health interventions. Yet many states don’t require them, and school districts struggle to hire them.

PrEP, a Key HIV Prevention Tool, Isn’t Reaching Black Women

KFF Health News Original

New HIV infections occur disproportionately among Black women, but exclusionary marketing, fewer treatment options, and provider wariness have limited uptake of preexposure prophylaxis, or PrEP, drugs, which reduce the risk of contracting the virus.

An Arm and a Leg: John Green vs. Johnson & Johnson (Part 1)

Podcast

Pharmaceutical patents can drive up the costs of lifesaving medications. Hear what author and YouTube star John Green is doing to make tuberculosis drugs more accessible to the people who need them most.